Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:25:36.127Z.
Calculation as of: 2026-10-06T21:25:36.127Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 880033b02c1352d2eede0b9825b135807cf5616a7da0006e335be03a15b23327
EARNINGS YIELD
N/A
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$503.93M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$502.81M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$500.52M
Earnings Yield
4.87%
TTM Avg
3.42%
3Y Avg
5.62%
5Y Avg
4.98%
Market Cap
$516.76M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$519.25M
Earnings Yield
N/A
TTM Avg
516.44%
3Y Avg
516.44%
5Y Avg
516.44%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 908 Devices Inc. (MASS) | $505.87M | N/A | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $504.04M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $502.81M | N/A | N/A | N/A | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 4.87% | 3.42% | 5.62% | 4.98% |
| Oculis Holding AG (OCS)vs › | $498.52M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $519.25M | N/A | 516.44% | 516.44% | 516.44% |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | N/A | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.01M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-05-06 | 6.82% |
| 2026-05-05 | 7.76% |
| 2026-05-04 | 8.40% |
| 2026-05-01 | 8.08% |
| 2026-04-30 | 8.05% |
| 2026-04-29 | 8.46% |
| 2026-04-28 | 8.16% |
| 2026-04-27 | 8.16% |
| 2026-04-24 | 8.16% |
| 2026-04-23 | 8.14% |
| 2026-04-22 | 7.71% |
| 2026-04-21 | 7.58% |
| 2026-04-20 | 7.53% |
| 2026-04-17 | 7.68% |
| 2026-04-16 | 7.41% |
| 2026-04-15 | 7.46% |
| 2026-04-14 | 7.51% |
| 2026-04-13 | 7.64% |
| 2026-04-10 | 7.70% |
| 2026-04-09 | 7.90% |
| 2026-04-08 | 7.82% |
| 2026-04-07 | 8.14% |
| 2026-04-06 | 8.03% |
| 2026-04-02 | 8.32% |
| 2026-04-01 | 8.86% |
| 2026-03-31 | 8.99% |
| 2026-03-30 | 9.57% |
| 2026-03-27 | 9.52% |
| 2026-03-26 | 8.96% |
| 2026-03-25 | 8.70% |
| 2026-03-24 | 8.77% |
| 2026-03-23 | 9.00% |
| 2026-03-20 | 9.00% |
| 2026-03-19 | 9.03% |
| 2026-03-18 | 9.18% |
| 2026-03-17 | 8.84% |
| 2026-03-16 | 9.03% |
| 2026-03-13 | 9.06% |
| 2026-03-12 | 9.15% |
| 2026-03-11 | 8.79% |
| 2026-03-10 | 8.79% |
